References
- Chinese Academy of Sciences Chinese Flora Editorial Board: Chinese Journal of Medicine. Vol. 66, Beijing: Science Press; 1977. p. 86–89.
- Nanjing University of Chinese Medicine: Dictionary of Traditional Chinese Medicine. 2nd ed. Shanghai: Shanghai Science and Technology Press; 2006. p. 643–650.
- Sun LN, Chen WS, Yang Y, et al. Salvia przewalskii extract in the preparation of drugs for curing the glomerular nephritis. Chinese patent: CN 200710048139.
- Yang Y, Zhu B, Wu ZJ, et al. Effects of Salvia przewalskii Maxim. extract on whole blood viscosity in normal rats and its diuresis in water-loaded rats. Chin Hosp Pharm J. 2012;32:751–754.
- Dai DS, Liu X, Yang Y, et al. Protective effect of Salvia przewalskii extract on puromycin-induced podocyte injury. Am J Nephrol. 2015;42:216–227.
- Liu X, Liu Y, Yang Y, et al. Antioxidative stress effects of Salvia przewalskii extract in experimentally injured podocyte. Nephron. 2016;134:253–271.
- Bao W, Xia H, Liang Y, et al. Toll-like receptor 9 can be activated by endogenous mitochondrial DNA to induce podocyte apoptosis. Sci Rep. 2016;6:22579.
- Srivastava T, Sharma M, Yew KH, et al. LPS and PAN-induced podocyte injury in an in vitro model of minimal change disease: changes in TLR profile. J Cell Commun Signal. 2013;7:49–60.
- Ma J, Chadban SJ, Zhao CY, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy. Plos One. 2014;9:e97985.
- Cha JJ, Hyun YY, Lee MH, et al. Renal protective effects of toll-like receptor 4 signaling blockade in type 2 diabetic mice. Endocrinology. 2013;154:2144–2155.
- Smoyer WE, Ransom RF. Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. Faseb J. 2002;16:315–326.
- Diamond JR, Bonventre JV, Karnovsky MJ. A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int. 1986;29:478–483.
- Shiiki H, Sasaki Y, Nishino T, et al. Cell proliferation and apoptosis of the glomerular epithelial cells in rats with puromycin aminonucleoside nephrosis. Pathobiology. 1998;66:221–229.
- Suzuki T, Takemura H, Takemura H, et al. Puromycin aminonucleoside induces apoptosis and increases HNE in cultured glomerular epithelial cells. Free Radic Biol Med. 2001;31:615–623.
- Marshall CB, Pippin JW, Krofft RD, et al. Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo. Kidney Int. 2006;70:1962–1973.
- Ding X, Zhu F, Li T, et al. Numb protects renal proximal tubular cells from puromycin aminonucleoside-induced apoptosis through inhibiting Notch signaling pathway. Int J Biol Sci. 2011;7:269–278.
- Cao W, Guo XW, Zheng HZ, et al. Current progress of research on pharmacologic actions of salvianolic acid B. Chin J Integr Med. 2012;18:316–320.
- Li WG, Liang JY. Research progress of rosmarinic acid. Strait Pharm J. 2004;16:1–4.
- Liu J, Farmer JJ, Lane WS, et al. Calcineurin is a common target of cyclophilin–cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807–815.
- Shaw KT, Ho AM, Raghavan A, et al. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci USA. 1995;92:11205–11209.
- Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocyte is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med. 2008;14:931–938.
- Wang Y, Jarad G, Tripathi P, et al. Activation of NFAT signaling in podocyte causes glomerulosclerosis. J Am Soc Nephrol. 2010;21:1657–1666.
- Zhang Q, Shi SF, Zhu L, et al. Tacrolimus improves the proteinnuria remission in patients with refractory IgA nephropathy. Am J Nephrol. 2012;35:312–320.
- Shen X, Jiang H, Ying M, et al. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Sci Rep. 2016;6:32087.